Matthew B. Klein is on the board of Clearpoint Neuro, Inc. and President, Chief Executive Officer & Director at PTC Therapeutics, Inc. and Clinical Associate Professor at Stanford University.

He previously was Director at BioElectron Technology Corp., Chief Medical Officer & Senior Vice President for Edison Pharmaceuticals, Inc. and Chairman-Restorative Burn Surgery at the University of Washington.

Matthew B. Klein received a doctorate from Yale University, an undergraduate degree from the University of Pennsylvania and a graduate degree from UW School of Public Health.